While the artificial intelligence (AI) revolution has been undeniably important in lifting the broader market, it would be ...
Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in ...
DALLAS, TX, Dec. 04, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, ...
Psychemedics (PMD) announced that, following the approval of the Company’s stockholders at its Annual Meeting of Stockholders held on November ...
has launched an investigation into potential stock manipulation related to and following its recent reverse stock split, which was effective as of October 16, 2024. This decision follows a ...
Mainz Biomed partners with Thermo Fisher to develop advanced colorectal cancer screening tools while enhancing ColoAlert for ...
TransCode Therapeutics (NASDAQ:RNAZ) will execute its previously announced 1-for-33 reverse stock split on Dec. 4, 2024. The company’s common stock is expected to begin trading on a split-adjusted ...
Shares of noco-noco Inc. (NASDAQ:NCNC – Free Report) are set to reverse split before the market opens on Friday, December 20th. The 1-50 reverse split was announced on Thursday, October 17th. The ...
TransCode Therapeutics shares are trading lower by 16% during Monday's session. The company announced a 1-for-33 reverse ...
Aptevo Therapeutics (APVO) announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-37. The Reverse Stock Split is expected to become ...
SEATTLE, WA / ACCESSWIRE / November 29, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), today announced that it will conduct a reverse stock split of its outstanding ...
SEATTLE, WA / ACCESSWIRE / November 29, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), today announced that it will conduct a reverse stock split of its outstanding shares ...